Friday, May 20, 2022

Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders

Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

from Latest Science News -- ScienceDaily https://ift.tt/vbSfPCx
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Common pesticide linked to more than double the risk of Parkinson’s disease

Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s disease. People...